
Sign up to save your podcasts
Or


Insurers can make or break drug developers, politicians can derail profits, and tax inversions are dead in the water -- should investors avoid healthcare stocks?
The theme for this week of Industry Focus brings Motley Fool’s summer interns into the studio to learn more about different industries and companies. Minashsha Lamisa wants to know: “What are the potential effects of the recent Orlando tragedy on the gun industry?”
It’s interns week on the Motley Fool’s Industry Focus: Financials edition podcast, a special week when this summer’s most Foolish interns have the chance to pepper host Gaby Lapera and analyst Jay Jenkins with all the financial industry related questions they’ve been thinking but never had the chance to ask.
The theme for this week of Industry Focus brings Motley Fool’s summer interns into the studio to learn more about different industries and companies. Minashsha Lamisa wants to know: “What are the potential effects of the recent Orlando tragedy on the gun industry?”
It’s interns week on the Motley Fool’s Industry Focus: Financials edition podcast, a special week when this summer’s most Foolish interns have the chance to pepper host Gaby Lapera and analyst Jay Jenkins with all the financial industry related questions they’ve been thinking but never had the chance to ask.
We run through Microsoft’s $26 billion purchase of LinkedIn, explain the details of the deal and whether or not it makes sense.
We run through Microsoft’s $26 billion purchase of LinkedIn, explain the details of the deal and whether or not it makes sense.
Explaining diabetes, its various treatment options, and what the future may have in store for this disease.
Major U.S. automakers trade at historically low valuations despite huge sales success and spectacular profits. How can this be? The Motley Fool’s John Rosevear and Sean O’Reilly dive in.
Explaining diabetes, its various treatment options, and what the future may have in store for this disease.
From the publisher's feed